Latest Press Releases Mar 09 2026 Vertex Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults With IgA Nephropathy Read More Mar 05 2026 Vertex to Participate in Upcoming March Investor Conferences Read More Mar 05 2026 Vertex to Present New Data on JOURNAVX® That Demonstrates Effective Pain Management Following Aesthetic and Reconstructive Procedures Read More Feb 17 2026 Vertex to Participate in TD Cowen 46th Annual Health Care Conference on March 3 Read More Feb 12 2026 Vertex Reports Fourth Quarter and Full Year 2025 Financial Results Read More Jan 20 2026 Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th Read More Load More Recent Media Library Items View All Date - Any -20212022202320242025 Tags 9Chief Executive Officer and PresidentDownload LibraryEmployee working at Vertex Manufacturing Center (VMC), Boston, MAEmployee working at Vertex Manufacturing Center, Boston, MAEntrance of The Jeffrey Leiden Center for Cell and Genetic Therapies, Boston, MAexeExecutive ChairmanExecutive Vice President and Chief Commercial OfficerExecutive Vice President and Chief Legal OfficerExecutive Vice President and Chief of Cell and Genetic TherapiesExecutive Vice President and Chief Operating & Financial OfficerExecutive Vice President and Chief Operating OfficerExecutive Vice President and Chief Patient OfficerExecutive Vice President and Chief Regulatory and Quality OfficerExecutive Vice President and Chief Scientific OfficerExecutive Vice President and Chief Technical Operations Officer, Head of Biopharmaceutical Sciences and Manufacturing Operations Executive Vice President and Former Chief Scientific OfficerExecutive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical OfficerExecutive Vice President, Global Research and Chief Scientific OfficerExterior of Vertex headquarters in Boston, MAExterior of Vertex headquarters in Paddington, UKExterior of Vertex research site in Oxford, UKExterior of Vertex research site in San Diego, CAImagesInterior of Vertex headquarters in Boston, MALiving with beta thalassemiaLiving with sickle cell diseaseLiving with transfusion-dependent beta thalassemiaLiving with transfusion-dependent thalassemiaMother to three daughters living with sickle cell diseaseResearcher in Vertex Oxford labResearcher in Vertex San Diego labResearchers in Vertex Boston labResearchers in Vertex Oxford labResearchers in Vertex San Diego lab Nia Tatsis, Ph.D. Executive Vice President and Chief Regulatory and Quality Officer Download Date - Any -20212022202320242025 Tags 9Chief Executive Officer and PresidentDownload LibraryEmployee working at Vertex Manufacturing Center (VMC), Boston, MAEmployee working at Vertex Manufacturing Center, Boston, MAEntrance of The Jeffrey Leiden Center for Cell and Genetic Therapies, Boston, MAexeExecutive ChairmanExecutive Vice President and Chief Commercial OfficerExecutive Vice President and Chief Legal OfficerExecutive Vice President and Chief of Cell and Genetic TherapiesExecutive Vice President and Chief Operating & Financial OfficerExecutive Vice President and Chief Operating OfficerExecutive Vice President and Chief Patient OfficerExecutive Vice President and Chief Regulatory and Quality OfficerExecutive Vice President and Chief Scientific OfficerExecutive Vice President and Chief Technical Operations Officer, Head of Biopharmaceutical Sciences and Manufacturing Operations Executive Vice President and Former Chief Scientific OfficerExecutive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical OfficerExecutive Vice President, Global Research and Chief Scientific OfficerExterior of Vertex headquarters in Boston, MAExterior of Vertex headquarters in Paddington, UKExterior of Vertex research site in Oxford, UKExterior of Vertex research site in San Diego, CAImagesInterior of Vertex headquarters in Boston, MALiving with beta thalassemiaLiving with sickle cell diseaseLiving with transfusion-dependent beta thalassemiaLiving with transfusion-dependent thalassemiaMother to three daughters living with sickle cell diseaseResearcher in Vertex Oxford labResearcher in Vertex San Diego labResearchers in Vertex Boston labResearchers in Vertex Oxford labResearchers in Vertex San Diego lab Jeffrey Leiden, M.D., Ph.D. Executive Chairman Download Date - Any -20212022202320242025 Tags 9Chief Executive Officer and PresidentDownload LibraryEmployee working at Vertex Manufacturing Center (VMC), Boston, MAEmployee working at Vertex Manufacturing Center, Boston, MAEntrance of The Jeffrey Leiden Center for Cell and Genetic Therapies, Boston, MAexeExecutive ChairmanExecutive Vice President and Chief Commercial OfficerExecutive Vice President and Chief Legal OfficerExecutive Vice President and Chief of Cell and Genetic TherapiesExecutive Vice President and Chief Operating & Financial OfficerExecutive Vice President and Chief Operating OfficerExecutive Vice President and Chief Patient OfficerExecutive Vice President and Chief Regulatory and Quality OfficerExecutive Vice President and Chief Scientific OfficerExecutive Vice President and Chief Technical Operations Officer, Head of Biopharmaceutical Sciences and Manufacturing Operations Executive Vice President and Former Chief Scientific OfficerExecutive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical OfficerExecutive Vice President, Global Research and Chief Scientific OfficerExterior of Vertex headquarters in Boston, MAExterior of Vertex headquarters in Paddington, UKExterior of Vertex research site in Oxford, UKExterior of Vertex research site in San Diego, CAImagesInterior of Vertex headquarters in Boston, MALiving with beta thalassemiaLiving with sickle cell diseaseLiving with transfusion-dependent beta thalassemiaLiving with transfusion-dependent thalassemiaMother to three daughters living with sickle cell diseaseResearcher in Vertex Oxford labResearcher in Vertex San Diego labResearchers in Vertex Boston labResearchers in Vertex Oxford labResearchers in Vertex San Diego lab Vertex International Headquarters Paddington – Lobby Download 915 KB Date - Any -20212022202320242025 Tags 9Chief Executive Officer and PresidentDownload LibraryEmployee working at Vertex Manufacturing Center (VMC), Boston, MAEmployee working at Vertex Manufacturing Center, Boston, MAEntrance of The Jeffrey Leiden Center for Cell and Genetic Therapies, Boston, MAexeExecutive ChairmanExecutive Vice President and Chief Commercial OfficerExecutive Vice President and Chief Legal OfficerExecutive Vice President and Chief of Cell and Genetic TherapiesExecutive Vice President and Chief Operating & Financial OfficerExecutive Vice President and Chief Operating OfficerExecutive Vice President and Chief Patient OfficerExecutive Vice President and Chief Regulatory and Quality OfficerExecutive Vice President and Chief Scientific OfficerExecutive Vice President and Chief Technical Operations Officer, Head of Biopharmaceutical Sciences and Manufacturing Operations Executive Vice President and Former Chief Scientific OfficerExecutive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical OfficerExecutive Vice President, Global Research and Chief Scientific OfficerExterior of Vertex headquarters in Boston, MAExterior of Vertex headquarters in Paddington, UKExterior of Vertex research site in Oxford, UKExterior of Vertex research site in San Diego, CAImagesInterior of Vertex headquarters in Boston, MALiving with beta thalassemiaLiving with sickle cell diseaseLiving with transfusion-dependent beta thalassemiaLiving with transfusion-dependent thalassemiaMother to three daughters living with sickle cell diseaseResearcher in Vertex Oxford labResearcher in Vertex San Diego labResearchers in Vertex Boston labResearchers in Vertex Oxford labResearchers in Vertex San Diego lab Vertex Logo with Tagline Download 2 MB | 2951 x 1952 Mediainfo@VRTX.com
Mar 09 2026 Vertex Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults With IgA Nephropathy Read More
Mar 05 2026 Vertex to Present New Data on JOURNAVX® That Demonstrates Effective Pain Management Following Aesthetic and Reconstructive Procedures Read More
Feb 17 2026 Vertex to Participate in TD Cowen 46th Annual Health Care Conference on March 3 Read More
Jan 20 2026 Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th Read More
